XORTX Therapeutics Inc (XRTX)
2.68
+0.08
(+3.13%)
USD |
NASDAQ |
May 03, 16:00
2.68
0.00 (0.00%)
After-Hours: 20:00
XORTX Therapeutics 1 Year Total Returns (Daily): -56.62% for May 2, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 02, 2024 | -56.62% |
May 01, 2024 | -58.49% |
April 30, 2024 | -55.76% |
April 29, 2024 | -54.12% |
April 26, 2024 | -48.58% |
April 25, 2024 | -54.32% |
April 24, 2024 | -52.25% |
April 23, 2024 | -55.29% |
April 22, 2024 | -54.38% |
April 19, 2024 | -55.36% |
April 18, 2024 | -55.41% |
April 17, 2024 | -54.45% |
April 16, 2024 | -52.72% |
April 15, 2024 | -50.89% |
April 12, 2024 | -45.75% |
April 11, 2024 | -41.04% |
April 10, 2024 | -27.38% |
April 09, 2024 | -23.03% |
April 08, 2024 | -21.12% |
April 05, 2024 | -25.25% |
April 04, 2024 | -26.00% |
April 03, 2024 | -19.75% |
April 02, 2024 | -19.37% |
April 01, 2024 | -13.04% |
March 28, 2024 | -8.66% |
Date | Value |
---|---|
March 27, 2024 | -17.54% |
March 26, 2024 | -12.06% |
March 25, 2024 | -11.48% |
March 22, 2024 | -3.05% |
March 21, 2024 | 14.33% |
March 20, 2024 | 1.62% |
March 19, 2024 | 10.00% |
March 18, 2024 | 7.78% |
March 15, 2024 | 11.54% |
March 14, 2024 | 13.57% |
March 13, 2024 | 4.18% |
March 12, 2024 | 0.50% |
March 11, 2024 | -7.41% |
March 08, 2024 | -4.50% |
March 07, 2024 | -7.21% |
March 06, 2024 | 24.86% |
March 05, 2024 | -9.61% |
March 04, 2024 | -35.22% |
March 01, 2024 | -35.04% |
February 29, 2024 | -42.62% |
February 28, 2024 | -37.06% |
February 27, 2024 | -51.69% |
February 26, 2024 | -44.16% |
February 23, 2024 | -54.61% |
February 22, 2024 | -52.13% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-82.19%
Minimum
Oct 11 2022
398.4%
Maximum
Sep 07 2021
-3.95%
Average
-27.52%
Median
Jan 12 2022
1 Year Total Returns (Daily) Benchmarks
ImmunoPrecise Antibodies Ltd | -50.78% |
Acasti Pharma Inc | 16.71% |
Aurinia Pharmaceuticals Inc | -55.44% |
Edesa Biotech Inc | -40.85% |
Lexaria Bioscience Corp | 60.22% |